M Rylander
-
- Antibiotic Use and Resistance 3
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 6
- Microbiology top 10%
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing 6
-
- Neuroscience of respiration and sleep 3
-
- Antibiotics Pharmacokinetics and Efficacy 7
-
- Neonatal Health and Biochemistry 4
-
- Antimicrobial Resistance in Staphylococcus 4
-
- Neonatal Respiratory Health Research 3
- Co-authors
- Gerd FaxeliusBaldvin JónssonHans O. HallanderS RingertzS. Ragnar NorrbyC. E. NordPer MontanM. Hedberg
- Journals
- Acta Paediatrica (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)
- Partner nations
- SwedenSwitzerlandFinland
In The Last Decade
M Rylander
19 papers receiving 359 citations
Peers
Comparison fields: 5 of 62
- Applied Microbiology and Biotechnology 25
- Molecular Medicine 54
- Microbiology 66
- Clinical Biochemistry 50
- Endocrine and Autonomic Systems 49
Countries citing papers authored by M Rylander
This map shows the geographic impact of M Rylander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Rylander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Rylander more than expected).
Fields of papers citing papers by M Rylander
This network shows the impact of papers produced by M Rylander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Rylander. The network helps show where M Rylander may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M Rylander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 16 | |
| 2 | 2000 | 25 | |
| 3 | 1999 | 15 | |
| 4 | 1999 | 1 | |
| 5 | 1998 | 60 | |
| 6 | 1998 | 54 | |
| 7 | 1995 | 4 | |
| 8 | 1994 | 36 | |
| 9 | 1993 | 9 | |
| 10 | 1992 | 26 | |
| 11 | 1991 | 20 | |
| 12 | 1991 | 4 | |
| 13 | 1991 | 19 | |
| 14 | 1990 | 5 | |
| 15 | 1989 | 8 | |
| 16 | In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. | 1988 | 41 |
| 17 | 1983 | 8 | |
| 18 | Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages. | 1978 | 18 |
| 19 | 1978 | 1 |
About M Rylander
M Rylander is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 19 papers that have together received 370 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (6 papers), Antibiotic Resistance in Bacteria (6 papers), Neonatal Health and Biochemistry (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Antibiotic Use and Resistance (3 papers), Neonatal Respiratory Health Research (3 papers) and Neuroscience of respiration and sleep (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (25 citations), Molecular Medicine (54 citations) and Microbiology (66 citations). M Rylander has collaborated with scholars based in Sweden, Switzerland and Finland. Frequent co-authors include Gerd Faxelius, Baldvin Jónsson, Hans O. Hallander, S Ringertz, S. Ragnar Norrby, C. E. Nord, Per Montan, M. Hedberg, Charlotta Edlund and Ragnar Norrby. Their work appears in journals such as Acta Paediatrica, Antimicrobial Agents and Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy and International Journal of STD & AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.